Differences in Hypertension and Stage II Hypertension by Demographic and Risk Factors, Obtained by Two Different Protocols in US Adults: National Health and Nutrition Examination Survey, 2017–2018
Supporting Files
-
7 01 2022 ; 7-01-
-
Available in CDC Stacks on 2023-07-01T00:00:00Z
File Language:
English
Details
-
Alternative Title:Am J Hypertens
-
Personal Author:
-
Description:BACKGROUND ; To compare prevalence of hypertension and stage II hypertension assessed by 2 blood pressure (BP) observation protocols. ; METHODS ; Participants aged 18 years and older (n = 4,689) in the National Health and Nutrition Examination Survey (NHANES 2017–2018) had their BP measured following 2 protocols: the legacy auscultation protocol (AP) and oscillometric protocol (OP). The order of protocols was randomly assigned. Prevalence estimates for hypertension (BP ≥130/80 mm Hg or use of medication for hypertension) and stage II hypertension (BP ≥140/90 mm Hg) were determined overall, by demographics, and by risk factors for each protocol. Ratios (OP% ÷ AP%) and kappa statistics were calculated. ; RESULTS ; Age-adjusted hypertension prevalence was 44.5% (95% confidence interval CI: 41.1%–48.0%) using OP and 45.1% (95% CI: 41.5%–48.7%) using AP, prevalence ratio = 0.99 (95% CI = 0.94–1.04). Age-adjusted stage II hypertension prevalence was 15.8% (95% CI: 13.6%–18.2%) using AP and 17.1% (95% CI: 14.7%–19.7%) using OP, prevalence ratio = 0.92 (95% CI = 0.81–1.04). For both hypertension and stage II hypertension, the prevalence ratios by demographics and by risk factors all included unity in their 95% CI, except for stage II hypertension in adults 60+ years (ratio: 0.88 95% CI: 0.78–0.98). Kappa for agreement between protocols for hypertension and stage II hypertension was 0.75 (95% CI = 0.71–0.79) and 0.67 (95% CI = 0.61–0.72), respectively. ; CONCLUSIONS ; In adults and for nearly all subcategories there were no significant differences in prevalence of hypertension and stage II hypertension between protocols, indicating that protocol change may not affect the national prevalence estimates of hypertension and stage II hypertension.
-
Subjects:
-
Keywords:
-
Source:Am J Hypertens. 35(7):619-626
-
Pubmed ID:35333925
-
Pubmed Central ID:PMC9745726
-
Document Type:
-
Funding:
-
Volume:35
-
Issue:7
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:5baf16ed7b7bcb0de556f06e0855b2f86b8276b6d1b05fef3185b64827b8b824a51102482d298b4a35d78bedba80172a8f69bc1e318dbfc987b0b846b9d3b857
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access